364 related articles for article (PubMed ID: 10981749)
61. Low-dose craniospinal radiation therapy for medulloblastoma.
Halberg FE; Wara WM; Fippin LF; Edwards MS; Levin VA; Davis RL; Prados MB; Wilson CB
Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):651-4. PubMed ID: 2004939
[TBL] [Abstract][Full Text] [Related]
62. Medulloblastoma: clinical presentation and management. Experience at the hospital for sick children, toronto, 1950-1980.
Park TS; Hoffman HJ; Hendrick EB; Humphreys RP; Becker LE
J Neurosurg; 1983 Apr; 58(4):543-52. PubMed ID: 6827349
[TBL] [Abstract][Full Text] [Related]
63. [Radiotherapy of medulloblastoma].
Wendt TG; Rohloff R; Bacherler B; Willich N; Lanksch W
Strahlenther Onkol; 1987 Jan; 163(1):1-5. PubMed ID: 3810472
[TBL] [Abstract][Full Text] [Related]
64. Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.
von Bueren AO; von Hoff K; Pietsch T; Gerber NU; Warmuth-Metz M; Deinlein F; Zwiener I; Faldum A; Fleischhack G; Benesch M; Krauss J; Kuehl J; Kortmann RD; Rutkowski S
Neuro Oncol; 2011 Jun; 13(6):669-79. PubMed ID: 21636711
[TBL] [Abstract][Full Text] [Related]
65. Characteristics and outcomes of medulloblastoma in adults.
Ang C; Hauerstock D; Guiot MC; Kasymjanova G; Roberge D; Kavan P; Muanza T
Pediatr Blood Cancer; 2008 Nov; 51(5):603-7. PubMed ID: 18649371
[TBL] [Abstract][Full Text] [Related]
66. M4 protocol for cerebellar medulloblastoma: supratentorial radiotherapy may not be avoided.
Bouffet E; Bernard JL; Frappaz D; Gentet JC; Roche H; Tron P; Carrie C; Raybaud C; Joannard A; Lapras C
Int J Radiat Oncol Biol Phys; 1992; 24(1):79-85. PubMed ID: 1512166
[TBL] [Abstract][Full Text] [Related]
67. Medulloblastoma: long-term results for patients treated with definitive radiation therapy during the computed tomography era.
Merchant TE; Wang MH; Haida T; Lindsley KL; Finlay J; Dunkel IJ; Rosenblum MK; Leibel SA
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):29-35. PubMed ID: 8823256
[TBL] [Abstract][Full Text] [Related]
68. Reappraisal of clinical outcome in adult medulloblastomas with emphasis on patterns of relapse.
Chargari C; Feuvret L; Levy A; Lamproglou I; Assouline A; Hemery C; Ghorbal L; Lopez S; Tep B; G GB; Lang P; Laigle-Donadey F; Cornu P; Mazeron JJ; Simon JM
Br J Neurosurg; 2010 Aug; 24(4):460-7. PubMed ID: 20726753
[TBL] [Abstract][Full Text] [Related]
69. Cerebellar medulloblastomas in adults.
Ildan F; Cetinalp E; Bağdatoğlu H; Boyar B; Haciyakupoğlu S; Karadayi A
Neurosurg Rev; 1994; 17(3):205-9. PubMed ID: 7838399
[TBL] [Abstract][Full Text] [Related]
70. Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients.
Carrie C; Lasset C; Alapetite C; Haie-Meder C; Hoffstetter S; Demaille MC; Kerr C; Wagner JP; Lagrange JL; Maire JP
Cancer; 1994 Oct; 74(8):2352-60. PubMed ID: 7922986
[TBL] [Abstract][Full Text] [Related]
71. [Frontal relapse of medulloblastoma. Causes and consequences (a case report)].
Kochbati L; Ghorbel I; Chaari N; Besbes M; Maalej M
Cancer Radiother; 2008 Dec; 12(8):860-2. PubMed ID: 18571966
[TBL] [Abstract][Full Text] [Related]
72. [Adult medulloblastomas: our experience].
Rodríguez-Mena R; Barbella-Aponte RA; Gallego-Sánchez JM; Barcia-Mariño C
Neurocirugia (Astur); 2011 Dec; 22(6):488-97. PubMed ID: 22167279
[TBL] [Abstract][Full Text] [Related]
73. Importance of patient evaluation for long-term survival in medulloblastoma recurrence.
La Marca F; Tomita T
Childs Nerv Syst; 1997 Jan; 13(1):30-4. PubMed ID: 9083699
[TBL] [Abstract][Full Text] [Related]
74. Collins' law. Prediction of recurrence or cure in childhood medulloblastoma?
Sure U; Berghorn WJ; Bertalanffy H
Clin Neurol Neurosurg; 1997 May; 99(2):113-6. PubMed ID: 9213055
[TBL] [Abstract][Full Text] [Related]
75. [Medulloblastomas--the results after postoperative radiotherapy with and without adjuvant chemotherapy].
Grabenbauer GG; Löhnert C; Erhardt J; Buchfelder M; Neubauer U; Beck JD; Reitz S; Seyer H; Thierauf P; Fietkau R
Strahlenther Onkol; 1993 Apr; 169(4):213-21. PubMed ID: 8488458
[TBL] [Abstract][Full Text] [Related]
76. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ
Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043
[TBL] [Abstract][Full Text] [Related]
77. Quality control of low dose craniospinal irradiation for low risk medulloblastoma.
Benk V; Bouhnik H; Raquin MA; Kalifa C; Habrand JL
Br J Radiol; 1995 Sep; 68(813):1009-13. PubMed ID: 7496681
[TBL] [Abstract][Full Text] [Related]
78. Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy.
Rutkauskiene G; Labanauskas L
Medicina (Kaunas); 2005; 41(12):1026-34. PubMed ID: 16401959
[TBL] [Abstract][Full Text] [Related]
79. Prognostic factors for medulloblastoma.
Jenkin D; Shabanah MA; Shail EA; Gray A; Hassounah M; Khafaga Y; Kofide A; Mustafa M; Schultz H
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):573-84. PubMed ID: 10837938
[TBL] [Abstract][Full Text] [Related]
80. Adult medulloblastoma: multiagent chemotherapy.
Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
